Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000202121

Medchemexpress LLC Val-Ala-PABC-Exatecan (trifluoroacetate) | 2928571-45-1 | 868.83 g·mol⁻¹ | C42H44F4N6O10 | 5 MG
SDP

Catalog No. 5000202121
Encompass_Preferred

Val-Ala-PABC-Exatecan (trifluoroacetate) is a drug-linker conjugate that combines a cleavable Val-Ala-PABC peptide linker with the topoisomerase I inhibitor exatecan. Supplied as the trifluoroacetate salt in milligram quantities, it is intended for research use in antibody-drug conjugate (ADC) synthesis and conjugation workflows.

  • Contains a cleavable Val-Ala-PABC peptide linker.
  • Delivers exatecan, a topoisomerase I inhibitor payload.
  • Supplied as the trifluoroacetate salt for handling stability.
  • Available in milligram quantities suitable for conjugation workflows.
  • Intended for research use only; not for human or clinical use.

Catalog No. 50-002-02121 Supplier Medchemexpress LLC Supplier No. HY147095A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Val-Ala-PABC-Exatecan (trifluoroacetate) is a drug-linker conjugate that combines a cleavable Val-Ala-PABC peptide linker with the topoisomerase I inhibitor exatecan. Supplied as the trifluoroacetate salt in milligram quantities, it is intended for research use in antibody-drug conjugate (ADC) synthesis and conjugation workflows.

  • Contains a cleavable Val-Ala-PABC peptide linker.
  • Delivers exatecan, a topoisomerase I inhibitor payload.
  • Supplied as the trifluoroacetate salt for handling stability.
  • Available in milligram quantities suitable for conjugation workflows.
  • Intended for research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.